tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Tenax Therapeutics management to meet with Piper Sandler
PremiumThe FlyTenax Therapeutics management to meet with Piper Sandler
2M ago
Optimistic Buy Rating for Tenax Therapeutics Driven by Strong Patent Portfolio and Market Potential of Levosimendan
Premium
Ratings
Optimistic Buy Rating for Tenax Therapeutics Driven by Strong Patent Portfolio and Market Potential of Levosimendan
2M ago
Tenax announces EPO intention to grant patent for levosimendan in PH-HFpEF
Premium
The Fly
Tenax announces EPO intention to grant patent for levosimendan in PH-HFpEF
2M ago
Tenax Therapeutics reports Q2 EPS (27c), consensus (45c)
PremiumThe FlyTenax Therapeutics reports Q2 EPS (27c), consensus (45c)
4M ago
Tenax Therapeutics trading resumes
Premium
The Fly
Tenax Therapeutics trading resumes
5M ago
Tenax Therapeutics trading halted, volatility trading pause
Premium
The Fly
Tenax Therapeutics trading halted, volatility trading pause
5M ago
Tenax Therapeutics  reports Q1 EPS (28c), consensus (41c)
PremiumThe FlyTenax Therapeutics reports Q1 EPS (28c), consensus (41c)
7M ago
Tenax Therapeutics sees cash, equivalents funding company through 2027
Premium
The Fly
Tenax Therapeutics sees cash, equivalents funding company through 2027
7M ago
Tenax Therapeutics Advances Cardiopulmonary Therapies
Premium
Company Announcements
Tenax Therapeutics Advances Cardiopulmonary Therapies
7M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100